Abstract | OBJECTIVE: METHODS: We carried out a longitudinal and prospective study between October '92 and June '99 comprising 20 patients with ages ranging from 12 days to 7 years (mean of 2.8 years). We employed a double immunosuppression protocol with cyclosporine and azathioprine and induction therapy with polyclonal antithymocyte serum. Survival and complications resulting from the immunosuppression protocol were analyzed. RESULTS: The double immunosuppression protocol and the induction therapy with polyclonal antithymocyte serum resulted in an actuarial survival curve of 90% and 78.2% at 1 and 6 years, respectively, with a mean follow-up period of 3.6 years. One patient died due to acute rejection 40 days after transplantation; another patient died 2 years after transplantation due to lymphoproliferative disorder; a third patient died because of primary failure of the graft; and a fourth patient died due to bronchopneumonia. The major complications were as follows: acute rejection, infection, nephrotoxicity, and systemic hypertension. The means of rejection and infection episodes per patient were 2.9 and 3.4, respectively. After one year of transplantation, a slight reduction in the creatinine clearance and systemic hypertension were observed in 7 (38.9%) patients. CONCLUSION:
|
Authors | E Azeka, M Barbero-Marcial, M Jatene, P R Camargo, J O Auler, E Atik, J A Ramires, M Ebaid |
Journal | Arquivos brasileiros de cardiologia
(Arq Bras Cardiol)
Vol. 74
Issue 3
Pg. 197-208
(Mar 2000)
ISSN: 0066-782X [Print] Brazil |
PMID | 10951823
(Publication Type: Journal Article)
|
Topics |
- Cardiomyopathies
(surgery)
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Graft Rejection
(diagnosis)
- Heart Defects, Congenital
(surgery)
- Heart Failure
(surgery)
- Heart Transplantation
(adverse effects, mortality)
- Humans
- Immunosuppression Therapy
(adverse effects, methods)
- Infant
- Infant, Newborn
- Longitudinal Studies
- Male
- Prospective Studies
- Survival Analysis
|